Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
123.50    1.50 (1.24%)
Bid:
121.00
Ask:
123.50
Spread: 2.50 (2.066%)
Market Cap: £196.76m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Form 8.5 (EPT/NON-RI)

30 May 2024 10:34

RNS Number : 4712Q
Cavendish Securities PLC
30 May 2024
 

FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Cavendish Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Redcentric PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Redcentric PLC

(d) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

29/05/2024

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

ORD 0.1P

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

21505

0.01

-60000

 

 

 

 

-0.04

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

TOTAL:

21505

 

0.01

-60000

 

 

 

-0.04

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

ORD 0.1P

Buy

5887

 

 

150

 

 

 

 

 

 

147.25

 

 

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

30/05/2024

Contact name:

Nancy Dyer

Telephone number:

0207 220 0594

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEOUROKRSOUVORR
Date   Source Headline
27th May 202512:00 pmRNSExercise of Options
27th May 20257:00 amRNSDirectorate Change
14th May 20257:00 amRNSExercise of Options
7th May 20257:00 amRNSTrading Update & CEO Appointment
25th Apr 20257:00 amRNSExercise of Options
3rd Apr 20257:00 amRNSExecutive Director Change
2nd Apr 20257:00 amRNSExercise of Options
21st Mar 20253:00 pmRNSExercise of Options
19th Feb 202512:15 pmRNSHolding(s) in Company
17th Feb 20257:00 amRNSExercise of Options
12th Feb 202511:00 amRNSExercise of Options
6th Feb 20257:00 amRNSHolding(s) in Company
5th Feb 202510:00 amRNSExercise of Options
30th Jan 20257:00 amRNSHolding(s) in Company
29th Jan 20257:00 amRNSExercise of Options
27th Jan 20257:00 amRNSBoard Change
20th Jan 20257:00 amRNSDirectorate Change - Group CEO Appointment
6th Jan 20254:00 pmRNSExercise of Options
13th Dec 20245:00 pmRNSExercise of Options
28th Nov 20247:00 amRNSExercise of Options
20th Nov 20247:00 amRNSHalf Year Results
4th Nov 202411:45 amRNSHolding(s) in Company
4th Nov 202411:30 amRNSHolding(s) in Company
1st Nov 20247:00 amRNSBoard Changes
25th Oct 20247:00 amRNSDirector/PDMR Shareholding
11th Oct 20247:00 amRNSExercise of Options
9th Oct 202410:15 amRNSExercise of Options
8th Oct 20247:00 amRNSSave As You Earn Share Option Scheme
4th Oct 20243:00 pmRNSExercise of Options
2nd Oct 20245:30 pmRNSExercise of Options
2nd Oct 20247:00 amRNSGrant of Options and PDMR Shareholding
1st Oct 20247:00 amRNSExercise of Options
27th Sep 20242:07 pmRNSResult of AGM
2nd Sep 20242:41 pmRNSPublication of Annual Report and Notice of AGM
23rd Aug 20242:36 pmRNSDirector/PDMR Shareholding
22nd Aug 20247:00 amRNSExercise of Options
15th Aug 20247:00 amRNSPreliminary results announcement FY24
8th Aug 20247:00 amRNSNotice of Results
7th Jun 202410:21 amRNSForm 8.5 (EPT/NON-RI)
6th Jun 20244:56 pmPRNStatement regarding Redcentric plc ("Redcentric")
6th Jun 202412:00 pmPRNForm 8.3 - Redcentric Plc
6th Jun 202410:25 amRNSForm 8.5 (EPT/NON-RI)
5th Jun 20242:29 pmRNSForm 8.3 - Redcentric plc
5th Jun 20249:57 amPRNForm 8.3 - Redcentric Plc
5th Jun 20247:00 amRNSForm 8.3 - Redcentric PLC
4th Jun 202412:02 pmPRNForm 8.3 - Redcentric Plc
3rd Jun 20245:56 pmRNSForm 8.3 - Redcentric PLC
3rd Jun 20241:34 pmEQSForm 8.3 - Apex Fundrock Limited : Re Redcentric plc
3rd Jun 202411:39 amPRNForm 8.3 - Redcentric Plc
3rd Jun 20249:20 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.